|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/5365 | (2006.01) |
| A61K 31/5365 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/2018 | (2013.01) | ||
| A61P 31/18 | (2006.01) | ||
| A61P 31/18 | (2018.01) | ||
| A61K 9/28 | (2006.01) | ||
| A61K 9/2009 | (2013.01) | ||
| A61K 9/2027 | (2013.01) | ||
| A61K 9/2054 | (2013.01) | ||
| A61K 9/2059 | (2013.01) | ||
| A61K 9/2095 | (2013.01) | ||
| A61K 9/284 | (2013.01) |
| (11) | Number of the document | 4171572 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21737779.5 |
| Date of filing the European patent application | 2021-06-23 | |
| (97) | Date of publication of the European application | 2023-05-03 |
| (45) | Date of publication and mention of the grant of the patent | 2025-05-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2021/055533 |
| Date | 2021-06-23 |
| (87) | Number | WO 2021/260567 |
| Date | 2021-12-30 |
| (30) | Number | Date | Country code |
| 202009684 | 2020-06-25 | GB |
| (72) |
CONN, Ian Paul , GB
DAVIES, Mark Robert , GB
HEAFIELD, Joanne , GB
HOLTON, Michael , GB
MORTIMER, Neil , GB
|
| (73) |
VIIV Healthcare Company ,
Corporation Service Company
251 Little Falls Drive, Wilmington, Delaware 19808,
US
|
| (54) | DISPERSIBLE TABLET FORMULATIONS COMPRISING DOLUTEGRAVIR |
| DISPERSIBLE TABLET FORMULATIONS COMPRISING DOLUTEGRAVIR |